Sign in

CIK 0001818382

  • Non-accelerated filer
  • Smaller reporting company

Humacyte, Inc.

Sign in to watch
Ticker
HUMA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
851763759
Phone
+1 919-313-9633
Business address
2525 EAST NORTH CAROLINA HIGHWAY 54, DURHAM, NC, 27713
Former names
Alpha Healthcare Acquisition Corp.
  1. 4 Open-market buy Director bought 1,797 shares at $4.44 ($7,979)
  2. 4 Open-market sale President, CEO and Director sold 1,500,000 shares at an average $4.40 ($6,606,799)
  3. 4 Open-market sale Director sold 1,500,000 shares at an average $4.40 ($6,606,799)
  4. 4 Exercise or conversion Director acquired 1,200 shares (option exercise)
  5. 4 Open-market sale Director sold 5,182 shares at an average $5.40 ($28,004)
  6. 4 Open-market sale Director sold 446,378 shares at an average $5.30 ($2,364,521)
  7. 4 Open-market sale President, CEO and Director sold 446,378 shares at an average $5.30 ($2,364,521)
  8. 4 Open-market buy President, CEO and Director bought 1,222 shares at $6.55 ($7,998)
  9. 4 Open-market buy Director bought 1,222 shares at $6.55 ($7,998)
  10. 4 Open-market sale Director sold 881,878 shares at an average $6.49 ($5,724,139)
  11. 4 Open-market sale President, CEO and Director sold 881,878 shares at an average $6.49 ($5,724,139)
  12. 4 Open-market sale CFO and Chief Corp. Deve. Off. sold 39,389 shares at $6.68 ($263,119)
  13. 4 Open-market buy Director bought 3,100 shares at $6.29 ($19,494)
  14. 4 Exercise or conversion Director acquired 39,389 shares (option exercise)
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 4 of 12 · 235 filings